| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.063 | 0.8 |